We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Craneware Plc | AQSE:CRW.GB | Aquis Stock Exchange | Ordinary Share | GB00B2425G68 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
30.00 | 1.35% | 2,250.00 | 2,200.00 | 2,300.00 | 2,251.00 | 2,220.00 | 2,220.00 | 410 | 16:29:38 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCRW
RNS Number : 5525O
Craneware plc
08 November 2016
Craneware plc
("Craneware", "the Group" or the "Company")
AGM Statement
8 November 2016 - Craneware plc (AIM: CRW.L), the leader in Value Cycle solutions for the US healthcare market, will be holding its Annual General Meeting today at 10am. At the meeting, Keith Neilson, CEO of the Company, will make the following statement:
"We continue to see positive results in the first few months of the current fiscal year. In September we announced the move back into double-digit revenue and adjusted EBITDA growth. With the impact of sales made during FY16 starting to contribute to revenue, combined with our sales pipeline and activity, we see that momentum continuing in the current year.
"The US healthcare market continues its evolution towards value-based care with a critical dependency on accurate financial and operating data. We are investing in our Value Cycle product suite to ensure we have the solutions to provide hospitals with tools that deliver insight into these areas of their operations, expanding our market opportunity and increasing our strategic value within our market.
"2017 will see some exciting developments for Craneware with the launch of Trisus Claims Informatics, the first product to be launched on our newly developed cloud-based Trisus Enterprise Value Platform; followed shortly thereafter by the launch of Trisus Patient Payment, a new fourth gateway product, operating within the patient access and engagement area.
"We are also making good progress within our newly formed Group business, Craneware Healthcare Intelligence, which is focused on the development of cost analytics software for the US healthcare industry.
"With our expanded offering and market opportunity, high levels of revenue visibility and favourable market backdrop, we believe we are just at the start of a long-term growth trajectory and are confident in the future success of Craneware."
For further information, please contact:
Craneware plc Peel Hunt Alma +44 (0)131 550 +44 (0)20 7418 +44 (0)208 004 3100 8900 4218 Keith Neilson, Dan Webster Caroline Forde CEO Craig Preston, Adrian Trimmings Hilary Buchanan CFO George Sellar Robyn McConnachie
About Craneware
Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.
Craneware is the leader in automated value cycle solutions that help US healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware has its headquarters in Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix employing over 200 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGMDGBDBRUGBGLR
(END) Dow Jones Newswires
November 08, 2016 02:00 ET (07:00 GMT)
1 Year Craneware Chart |
1 Month Craneware Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions